Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: KINIKSA PHARMACEUTICALS (UK), LTD.
Awarding agency: Department of Veterans Affairs / Department of Veterans Affairs
Funding agency: Department of Veterans Affairs / Department of Veterans Affairs
Period of performance: 2022-04-06 to 2023-05-31
Current total value of award: $195062.92
Description: RILONACEPT (ARCALYST) 220MG/VIL INJ